Related Experiment Videos
Treatment of typhoid fever and infectious diarrhoea with ciprofloxacin
1Department of Communicable and Tropical Disease, East Birmingham Hospital, UK.
Abstract:
Ciprofloxacin and other related fluorinated 4-quinolones have microbiological and pharmacokinetic properties that suggest they could be useful agents in the management of typhoid fever and bacterial gastroenteritis. Initial studies confirm that this is the case. Against fully sensitive Salmonella typhi ciprofloxacin is clinically as effective as chloramphenicol or co-trimoxazole. It is also effective treatment for antibiotic-resistant strains which cause epidemic and endemic infection throughout the world. Furthermore, ciprofloxacin appears to eliminate chronic carriage of Salm. typhi more efficiently than other antibiotics. Ciprofloxacin has excellent in-vitro activity against all the bacterial pathogens that commonly cause infective diarrhoea. There are limited data concerning its use in the treatment of shigella dysentery but, in appropriate situations, ciprofloxacin is effective treatment for salmonella enteritis and is also effective in infections complicated by septicaemia and bone and liver abscesses. Ciprofloxacin appears to be of benefit in Campylobacter jejuni enteritis and is effective in the treatment of travellers' diarrhoea were enterotoxigenic Escherichia coli and shigellae are most important.
Insights
Ciprofloxacin is an effective antibiotic for treating typhoid fever and bacterial gastroenteritis, including antibiotic-resistant strains. It also shows promise in eliminating chronic Salmonella typhi carriage and treating various diarrheal infections.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Ciprofloxacin and related fluorinated 4-quinolones possess properties suitable for managing typhoid fever and bacterial gastroenteritis.
- Salmonella typhi and other bacterial pathogens are common causes of diarrheal diseases globally.
Purpose of the Study:
- To evaluate the efficacy of ciprofloxacin in treating typhoid fever and bacterial gastroenteritis.
- To assess ciprofloxacin's effectiveness against both sensitive and resistant bacterial strains.
- To explore ciprofloxacin's role in managing chronic Salmonella typhi carriage and various diarrheal infections.
Main Methods:
- Clinical studies were conducted to assess ciprofloxacin's effectiveness.
- In-vitro activity against common bacterial pathogens causing infective diarrhea was evaluated.
- Comparative efficacy against standard treatments like chloramphenicol and co-trimoxazole was considered.
Main Results:
- Ciprofloxacin demonstrated clinical efficacy comparable to chloramphenicol and co-trimoxazole against sensitive Salmonella typhi.
- It proved effective against antibiotic-resistant strains of Salmonella typhi, addressing epidemic and endemic infections.
- Ciprofloxacin showed efficient elimination of chronic Salmonella typhi carriage and excellent in-vitro activity against common diarrheal pathogens.
- The drug was effective in treating salmonella enteritis, including complicated cases with septicaemia and abscesses, and Campylobacter jejuni enteritis.
- Ciprofloxacin was beneficial for travelers' diarrhea caused by enterotoxigenic Escherichia coli and shigellae.
Conclusions:
- Ciprofloxacin is a valuable therapeutic option for typhoid fever and bacterial gastroenteritis.
- Its effectiveness against resistant strains and chronic carriage makes it a significant advancement in managing these infections.
- Ciprofloxacin offers a broad spectrum of activity against common bacterial diarrheal pathogens.